Related Experiment Video
Updated: Aug 9, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Perceptions on Management of Atopic Dermatitis in Children Under 2 Years by Community Pediatricians: A Focus Group
Noor Hamideh1, Pooja Venkatesh2, Sharon Zhao3
1NYU Langone Grossman School of Medicine, New York, NY, USA.
Insights
Pediatricians face challenges treating atopic dermatitis (AD) in young children due to concerns about topical corticosteroid (TCS) use and adherence. Improved education and guidelines are needed for better AD management in infants and toddlers.
Area of Science:
- Pediatric dermatology
- Clinical practice research
- Qualitative health research
Background:
- Atopic dermatitis (AD) is prevalent in children under 2 years.
- Specific management guidelines for this age group are lacking.
- Undertreatment of AD in young children is a significant concern.
Purpose of the Study:
- To identify barriers to atopic dermatitis treatment in children under 2 years.
- To explore primary care pediatricians' (PCPs) suggested solutions for improving AD management.
- To understand the reasons behind the perceived undertreatment of AD in this vulnerable population.
Main Methods:
- Semi-structured focus groups were conducted with 17 primary care pediatricians.
- Qualitative data analysis employed an inductive approach.
- Discussions centered on addressing the undertreatment of atopic dermatitis in young children.
Main Results:
- Key barriers identified include hesitancy in using topical corticosteroids (TCS), poor caregiver adherence to recommendations, and under-documentation in electronic medical records (EMR).
- Pediatricians suggested enhanced education on TCS safety for caregivers and PCPs.
- Development of stepwise management guidelines and EMR aids were proposed solutions.
Conclusions:
- Addressing undertreatment of atopic dermatitis in children under 2 requires tackling TCS hesitancy and improving adherence.
- Further research is needed to develop and disseminate practical AD management guidelines for this age group.
- Educational initiatives and improved documentation tools are crucial for optimizing pediatric AD care.
Abstract:
Atopic dermatitis (AD) is a common skin condition and is undertreated in children under 2 years, whom there are no specific guidelines for. We sought to understand barriers to AD treatment and primary care pediatricians' (PCPs) suggested solutions. We conducted semi-structured focus groups (n = 5) with PCPs (n = 17) on how the undertreatment of AD can be addressed. Data were analyzed using an inductive qualitative approach. Participants noted that the perceived undertreatment of AD in children under 2 years could be explained by topical corticosteroid (TCS) use hesitancy, lack of caregiver adherence to PCP recommendations, and under-documentation of AD in the electronic medical record (EMR). Proposed suggestions for improving AD management included caregiver and PCP education on TCS safety; stepwise management guidelines for this age group; and EMR aids to help document and manage AD. Research is warranted to create and disseminate clinician-friendly AD management guidelines for this age group.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Nursing Management
First, in...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
COPD: Management Using Bronchodilators and Corticosteroids

